Measurement of paraoxonase and telomerase enzymes and HDL (high density lipoprotein) values and research of their possible relationships with each other in bloodserum of obese cats

Yıl 2021, Cilt: 6 Sayı: 3, 104 - 108, 31.12.2021

Tuğçe Dağ Şima Şahinduran

https://doi.org/10.24880/maeuvfd.920578

Öz

Today, obesity is seen as a serious health problem in domestic cats. Paraoxonase1 (PON1) is a negative acute phase protein with anti-inflammatory properties. PON1 is transported by linking to different parts of HDL in the blood and has a protective feature of HDL against oxidation. Telomerase is reverse transcriptase enzyme that synthesizes and protects telomeres. Telomere length becomes shorter due to stress, obesity, and lack of exercise. In this study, paraoxonase1, telomerase enzymes and HDL values in blood serum of obese and non-obese cats were measured and their relationships with each other were evaluated. Body fat ratio in cats with body fat measurement system, those above 30% were evaluated as obese, and those below 30% were evaluated as the control group. Paraoxonase1 (p<0.001), telomerase (p<0.001) and HDL (p<0.008) values showed a statistically significant difference between the both groups, it was found to be lower in the obese group compared to the control group. As a result; paraoxonase1 and telomerase enzymes which are parameters of oxidative stress and are known to decrease in inflammation, were also found to be decreased in obese cats. The fact that HDL values are lower than the control group is an indicator that there are diseases that occur together with obesity.

Anahtar Kelimeler

HDL, Obesity, Paraoxonase, Telomerase

Destekleyen Kurum

Burdur Mehmet Akif Ersoy Üniversitesi, Bilimsel Araştırma Projeleri Birimi

Proje Numarası

0626-YL-20

Teşekkür

This study was supported by Mehmet Akif Ersoy University Scientific Research Projects Commission (Project No: 0626-YL-20).

Kaynakça

• 1. Wall M, Cave NJ, Vallee E. Owner and cat-related risk factors for feline overweight or obesity. Front vet Sci. 2019; 6, 266.
• 2. Kobayashi M, Okada Y, Ueno H, Mizorogi T, Ohara K, Kawasumi K, Arai T. Effects of Supplementation with Anti-Inflammatory Compound Extracted from Herbs in Healthy and Obese Cats. Vet Med Res Rep. 2020; 11, 39.
• 3. Corbee RJ. Obesity in show cats. J Anim Physiol An. 2014; 98 (6): 1075-1080.
• 4. Leray V, Freuchet B, Le Bloc'h J, Jeusette I, Torre C. Nguyen P., Effect of citrus polyphenol and curcumin-supplemented diet on inflammatory state in obese cats. Br J Nutr. 2011; 106, S198 – S201.
• 5. Juretic D, Tadijanovic M, Rekic B, Simean-Rudolf V, Reiner E, Baricic M. Serum paraoxonase activities in hemodialyzed uremic patients: cohort study. Croatian Med J. 2001; 42, 146-150.
• 6. Özgün E. İsoproterenol ile deneysel miyokart infarktüsü oluşturulan sıçanlarda melatoninin serum paraoksonaz aktivitesine etkisi. Trakya Üniversitesi Tıp Fakültesi Tıbbi Biyokimya Anabilim Dalı, Edirne/ Türkiye, 2013.
• 7. Abdelouahed K, Kamtchueng SO, Ikhlef S, Berrougui H. The role of paraoxonase 1 in regulating HDL functionality during aging. Can J Physiol Pharmacol. 2017; 95 (10): 1254-1262.
• 8. Kotani K, Sakane N, Sano Y, et al. Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women. J Clin Biochem Nutr. 2009; 45, 329–334.
• 9. Costa LG, Cole TB, Furlong CE. Paraoxonase (PON1) and Detoxication of Nerve Agents. Handbook of Toxicology of Chemical Warfare Agent. 2015; 1089–1098.
• 10. Tiryakioğlu A, Özkan M, Kayım S, Bağcı Ö, Çeviker K, Tatar B, Yazkan R, Erdemoğlu E. Kanser Tanı ve Tedavisinde DNA’ya Yönelik Güncel Yaklaşımlar: Telomeraz/Tert. Mühendis Bilim Tasar Derg. 2016; 4(2): 125-131.
• 11. Andrews NP, Fujii H, Goronzy JJ, Weyand CM. Telomerase and immunological diseases of aging. Gerontology. 2010; 56, 390–403.
• 12. Hawthorne AJ, Butterwick RF. The feline body mass index ¬ a simple measure of body fat content in cats. WALTHAM Foc. 2000; 10(1): 32-¬33.
• 13. Bjornvad CR, Nielsen DH, Armstrong PJ, McEvoy F, Hoelmkjaer KM, Jensen KS, Kristensen AT. Evaluation of a nine-point body condition scoring system in physically inactive pet cats. AJVR. 2011; 72 (4): 433-437.
• 14. Rossi G, Giordano A, Pezzia F, Kjelgaard‐Hansen M, Paltrinieri S. Serum paraoxonase 1 activity in dogs: preanalytical and analytical factors and correlation with C‐reactive protein and alpha‐2‐globulin. Vet Clin Pathol. 2013; 42(3): 329-341.
• 15. Tvarijonaviciute A, Ceron JJ, Holden SL, Morris PJ, Biourge V, German AJ. Effects of weight loss in obese cats on biochemical analytes related to inflammation and glucose homeostasis. Domes Anim Endocrinol. 2012; 42(3): 129–141.
• 16. Cervellati C, Bonaccorsi G, Trentini A, Valacchi G, Sanz JM, Squerzanti M, Parladori R. Paraoxonase, arylesterase and lactonase activities of paraoxonase1 (PON1) in obese and severely obese women. Scand J Clin Lab Inv. 2018; 78(1-2): 18-24.
• 17. Pehlivan E. Obez Hastalarda Klotho ve Telomeraz İlişkisinin Değerlendirilmesi. Ege Ünivers. Tıp Fakül. İç Hast. Anabilim Dalı. İzmir/ Türkiye, 2017.
• 18. Quimby JM, Maranon DG, Battaglia CL, McLeland SM, Brock WT, Bailey SM. Feline chronic kidney disease is associated with shortened telomeres and increased cellular senescence. Am J Physiol Renal Physiol. 2013; 305(3): F295- F303.
• 19. Minamoto T. Lipoprotein Profiling in Dogs and Cats with Gastrointestinal Disease or Hepatic Disease. Doctoral dissertation, Texas A & M University, 2018.
• 20. Minamoto T, Walzem RL, Hamilton AJ, Hill SL, Payne HR, Lidbury JA, Steiner JM. Altered lipoprotein profiles in cats with hepatic lipidosis. J Feline Med Surg. 2019; 21(4): 363-372.
• 21. Wisselink MA, Koeman JP, Wensing T, De Bruijne J, Willemse T. Hyperlipoproteinaemia associated with atherosclerosis and cutaneous xanthomatosis in a cat. Vet Q. 1994; 16(4): 199-202.
• 22. Jordan E, Kley S, Le NA, Waldron M, Hoenig M. Dyslipidemia in obese cats. Domest Anim Eddocrinol. 2008; 35(3): 290-299.
• 23. Ferretti G, Bacchetti T, Moroni C, Savino S, Liuzzi A, Balzola F, Bicchiega V. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. J Clin Endocrinol Metab. 2005; 90 (3):1728-1733.
• 24. Ferretti G, Bacchetti T, Masciangelo S, Bicchiega V. HDL‐paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects. Obesity. 2010; 18(6): 1079-1084.